§ 1 Company name

The company’s name is Navamedic ASA. The company is a public limited company.

§ 2 Registered office

The company’s registered office is in the municipality of Oslo.

§ 3 Objective

The Company’s purpose is to develop, produce, market and sell pharmaceuticals and related products, provide connected consulting services and invest in related business.

§ 4 Share capital

The share capital of the Company is NOK 17,746,219.72, divided into 23,981,378 shares, each with a nominal value of NOK 0.74.

§ 5 Board of directors

The company’s board of directors shall consist of minimum 3 and maximum 7 directors pursuant to the further decision of the general meeting.

§ 6 Nomination committee

The company shall have a nomination committee. The nomination committee shall consist of two to three members. At least two of the members shall be shareholders or represent the shareholders. The nomination committee shall propose candidates to the annual general meeting in election of board members. The nomination committee shall also submit proposals on board remuneration. The term of the members of the nomination committee shall be up to 2 years at a time.

§ 7 General meeting

The ordinary general meeting shall consider and resolve approval of the annual accounts and the annual report. Shareholders who wish to attend the general meeting must give notice to the company no later than two business days prior to the general meeting in accordance with the board of directors detailed instructions.

Shareholders may cast advance votes in writing for matters that will be considered at the general meeting. Such votes may also be cast via electronic communication. The right to cast advance votes is contingent upon the existence of a satisfactory method for authenticating the identity of the sender. The board of directors shall determine whether or not such a method exists prior to each general meeting. The board of directors may stipulate detailed guidelines for casting and handling advance votes in writing. The notice of the general meeting must state whether or not advance voting is allowed and what guidelines may have been established for such advance voting.

Documents concerning matters to be considered at the general meeting may be made available on the company’s website. This is also applicable for documents that by law shall be included in or attached to the notice. In case documents are made available in such manner, the statutory requirements for distribution to shareholders shall not be applicable. A shareholder still have the right to receive documents concerning matters to be considered at the general meeting upon request.

§ 8 Transfer of shares

The company’s shares shall be freely transferable.